Silencing c-Myc Enhances the Antitumor Activity of Bufalin by Suppressing the HIF-1 alpha/SDF-1/CXCR4 Pathway in Pancreatic Cancer Cells

Liu, X; Zhou, YY; Peng, JM; Xie, B; Shou, QY; Wang, JH

Shou, QY (corresponding author), Zhejiang Chinese Med Univ, Clin Med Coll 2, Hangzhou, Peoples R China.; Wang, JH (corresponding author), Tongde Hosp Zhejiang Prov, Dept Clin Lab, Hangzhou, Peoples R China.

FRONTIERS IN PHARMACOLOGY, 2020; 11 ():

Abstract

Background Pancreatic cancer is one of the most aggressive malignancies. Bufalin, a traditional Chinese medicine, has been used to treat pancreatic ca......

Full Text Link